Vor Biopharma Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vor Biopharma Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Vor Biopharma Inc. Depreciation for the quarter ending June 30, 2024 was $900K, unchanged year-over-year.
  • Vor Biopharma Inc. Depreciation for the twelve months ending June 30, 2024 was $3.6M, a 11.2% increase year-over-year.
  • Vor Biopharma Inc. annual Depreciation for 2023 was $3.49M, a 38.3% increase from 2022.
  • Vor Biopharma Inc. annual Depreciation for 2022 was $2.53M, a 76.1% increase from 2021.
  • Vor Biopharma Inc. annual Depreciation for 2021 was $1.43M, a 137% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.49M +$967K +38.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $2.53M +$1.09M +76.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $1.43M +$829K +137% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $605K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.